Treatment and primary prevention in people who inject drugs for chronic hepatitis C infection: Is elimination possible in a high prevalence setting?

Por Gountas, Sypsa, Anagnostou, O., Martin, N.K, Vickerman, P., Kafetzopoulos, E., Hatzakis, A.
Publicado no Addiction (2017)

Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study

Por Martin, N K, Robey, I F, Gaffney, E A, Gillies, R J, Gatenby, R A, Maini, P K
Publicado em 2012

New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

Por Harris, R. J., Martin, N. K., Rand, E., Mandal, S., Mutimer, D., Vickerman, P., Ramsay, M. E., De Angelis, D., Hickman, M., Harris, H.E.
Publicado no J Viral Hepat (2016)

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy

Por Aspinall, E. J., Mitchell, W., Schofield, J., Cairns, A., Lamond, S., Bramley, P., Peters, S. E., Valerio, H., Tomnay, J., Goldberg, D. J., Mills, P. R., Barclay, S. T., Fraser, A., Dillon, J. F., Martin, N. K., Hickman, M., Hutchinson, S. J.
Publicado no J Viral Hepat (2016)

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact

Por Martin, N K, Foster, G R, Vilar, J, Ryder, S, E Cramp, M, Gordon, F, Dillon, J F, Craine, N, Busse, H, Clements, A, Hutchinson, S J, Ustianowski, A, Ramsay, M, Goldberg, D J, Irving, W, Hope, V, De Angelis, D, Lyons, M, Vickerman, P, Hickman, M
Publicado no J Viral Hepat (2015)